Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Truffot-Pernot

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 13, 2001
Iron and Mycobacterium tuberculosis infectionN Lounis, C Truffot-Pernot, J Grosset, et al.
The Journal of Infectious Diseases|August 1, 1994
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacinE Cambau, W Sougakoff, M Besson, et al.
Clinical and Experimental Immunology|June 1, 1989
Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of miceH F Lecoeur, P H Lagrange, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 miceC Perronne, Y Cohen, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophagesC Perronne, A Gikas, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2006
Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosisM Ibrahim, K Andries, N Lounis, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1990
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophagesC Perronne, A Gikas, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1992
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophagesY Cohen, C Perronne, C Truffot-Pernot, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 1998
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in miceJ Grosset, N Lounis, C Truffot-Pernot, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1994
Chloroquine does not enhance the activity of clarithromycin against multiplication of Mycobacterium avium within human macrophagesT Lazard, C Perronne, C Truffot-Pernot, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 13, 2001
Iron and Mycobacterium tuberculosis infectionN Lounis, C Truffot-Pernot, J Grosset, et al.
The Journal of Infectious Diseases|August 1, 1994
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacinE Cambau, W Sougakoff, M Besson, et al.
Clinical and Experimental Immunology|June 1, 1989
Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of miceH F Lecoeur, P H Lagrange, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 miceC Perronne, Y Cohen, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophagesC Perronne, A Gikas, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2006
Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosisM Ibrahim, K Andries, N Lounis, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1990
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophagesC Perronne, A Gikas, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1992
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophagesY Cohen, C Perronne, C Truffot-Pernot, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 1998
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in miceJ Grosset, N Lounis, C Truffot-Pernot, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1994
Chloroquine does not enhance the activity of clarithromycin against multiplication of Mycobacterium avium within human macrophagesT Lazard, C Perronne, C Truffot-Pernot, et al.
Pageof 8